tiprankstipranks
Trending News
More News >
Advertisement

BEDY - ETF AI Analysis

Compare

Top Page

BEDY

BNY Mellon Enhanced Dividend and Income ETF (BEDY)

Rating:67Neutral
Price Target:
BEDY, the BNY Mellon Enhanced Dividend and Income ETF, earns a solid overall rating thanks to several high-quality, diversified holdings like Johnson & Johnson and Texas Instruments, which bring strong financial performance, positive earnings sentiment, and long-term growth initiatives. Other major positions such as Cisco, Exxon Mobil, and JPMorgan also support the fund with robust balance sheets and strategic investments, though issues like high valuations, cash flow challenges, and segment-specific risks limit upside. Colgate-Palmolive appears to be one of the weaker links due to leverage and operational inefficiencies, and investors should note that some holdings face valuation and technical risks even as they contribute income and stability.
Positive Factors
Strong Top Holdings
Several top holdings, such as Johnson & Johnson and Exxon Mobil, are well-established companies that have historically delivered steady performance.
Sector Diversification
The ETF spreads its investments across multiple sectors, including Financials, Health Care, and Technology, reducing reliance on any single industry.
Moderate Expense Ratio
The ETF’s expense ratio is reasonable compared to many actively managed funds, helping investors retain more of their returns.
Negative Factors
High Financial Sector Exposure
With over a quarter of the portfolio in the Financial sector, the fund is vulnerable to downturns in this industry.
Limited Geographic Diversification
The ETF is heavily concentrated in U.S. companies, offering minimal exposure to international markets.
Small Asset Base
The fund’s relatively low assets under management could lead to less liquidity and higher trading costs for investors.

BEDY vs. SPDR S&P 500 ETF (SPY)

BEDY Summary

The BNY Mellon Enhanced Dividend and Income ETF (Ticker: BEDY) is an actively managed fund that focuses on large U.S. companies with strong financial health and the potential for steady dividend income. It invests in well-known names like Johnson & Johnson and Exxon Mobil, targeting value stocks that may be undervalued but have solid earnings potential. This ETF is a good choice for investors seeking income through dividends and long-term growth while diversifying their portfolio with stable, established companies. However, since the fund is heavily invested in financial and healthcare sectors, its performance could be impacted if these industries face challenges.
How much will it cost me?The BNY Mellon Enhanced Dividend and Income ETF (BEDY) has an expense ratio of 0.50%, which means you’ll pay $5 per year for every $1,000 invested. This is higher than the average for passively managed ETFs because BEDY is actively managed, requiring more research and decision-making by fund managers to select investments.
What would affect this ETF?The BNY Mellon Enhanced Dividend and Income ETF (BEDY) could benefit from a stable U.S. economy, as its focus on large-cap value stocks and sectors like financials, health care, and technology provides exposure to companies with strong fundamentals and dividend potential. However, rising interest rates or economic slowdowns could negatively impact financial and industrial sectors, which make up a significant portion of the ETF's holdings. Additionally, regulatory changes or sector-specific challenges in energy or health care could pose risks to its performance.

BEDY Top 10 Holdings

BEDY leans heavily on steady, dividend-friendly U.S. blue chips, with recent strength coming from Exxon Mobil, Johnson & Johnson, CME Group, and Colgate-Palmolive, all helping to pull the fund higher. Texas Instruments has also been rising, giving the portfolio a quiet tech kicker. On the flip side, financial names like JPMorgan and insurer Assurant, along with UnitedHealth, have been lagging and acting as a bit of a brake. Overall, the ETF is tilted toward U.S. financials and other large-cap value names, with no single stock dominating the story.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Cisco Systems3.65%$4.73M$308.49B29.18%
77
Outperform
Exxon Mobil3.55%$4.60M$631.60B38.90%
74
Outperform
Johnson & Johnson3.33%$4.31M$585.58B49.21%
78
Outperform
CME Group3.04%$3.93M$108.78B18.16%
74
Outperform
Omnicom Group2.85%$3.68M$24.85B0.06%
73
Outperform
Assurant2.79%$3.62M$10.77B7.50%
73
Outperform
Texas Instruments2.79%$3.61M$180.30B13.07%
78
Outperform
JPMorgan Chase2.78%$3.60M$775.45B26.16%
72
Outperform
L3Harris Technologies2.59%$3.35M$68.04B74.33%
70
Neutral
UnitedHealth2.54%$3.28M$258.91B-40.71%
72
Outperform

BEDY Technical Analysis

Technical Analysis Sentiment
Negative
Last Price
Price Trends
50DMA
27.45
Negative
100DMA
200DMA
Market Momentum
MACD
-0.09
Positive
RSI
36.05
Neutral
STOCH
22.53
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BEDY, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 27.85, equal to the 50-day MA of 27.45, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of -0.09 indicates Positive momentum. The RSI at 36.05 is Neutral, neither overbought nor oversold. The STOCH value of 22.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BEDY.

BEDY Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$130.32M0.50%
67
Neutral
$619.94M0.33%
71
Outperform
$500.79M0.56%
72
Outperform
$327.10M0.42%
72
Outperform
$315.55M0.71%
67
Neutral
$311.91M0.45%
70
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BEDY
BNY Mellon Enhanced Dividend and Income ETF
27.02
1.27
4.93%
TVAL
T. Rowe Price Value ETF
JDVL
John Hancock Disciplined Value Select ETF
FLV
American Century Focused Large Cap Value ETF
BASV
Brown Advisory Sustainable Value ETF
BLCV
BlackRock Large Cap Value ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement